Uncoupled angiogenesis and osteogenesis in nicotine-compromised bone healing

Journal of Bone and Mineral Research

Volumn 25, Issue 6, 2010, Pages 1305-1313

  Li, Ma ^a   Li, Wu Zheng ^a   Mai, Har Sham ^b   Lim, Kwong Cheung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiogenesis; Bone healing; Bone morphogenetic protein 2; Hypoxia inducible factor 1 ; Nicotine; Osteogenesis; Vascular endothelial growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINE; PLACEBO; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; FRACTURE HEALING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; NECK; NONHUMAN; PROTEIN EXPRESSION; RABBIT; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; UPREGULATION;

ANIMALS; ANTIGENS, CD31; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; COLLAGEN TYPE IV; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NICOTINE; OSTEOGENESIS, DISTRACTION; RABBITS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77953529300     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.19     Document Type: Article

References (78)

1. Balbani AP, Montovani JC. Methods for smoking cessation and treatment of nicotine dependence. Rev Bras Otorrinolaringol (Engl Ed). 2005;71:820-827.
2. Raikin SM, Landsman JC, Alexander VA, Froimson MI, Plaxton NA. Effect of nicotine on the rate and strength of long bone fracture healing. Clin Orthop Relat Res. 1998; 231-237.
3. Tonetti MS. Cigarette smoking and periodontal diseases: etiology and management of disease. Ann Periodontol. 1998;3:88-101.
4. Ma L, Zheng LW, Cheung LK. Inhibitory effect of nicotine on bone regeneration in mandibular distraction osteogenesis. Front Biosci. 2007;12:3256-3262.
5. Zheng LW, Ma L, Cheung LK. Changes in blood perfusion and bone healing induced by nicotine during distraction osteogenesis. Bone. 2008;43:355-361.
6. Glowacki J, Schulten AJ, Perrott D, Kaban LB. Nicotine impairs distraction osteogenesis in the rat mandible. Int J Oral Maxillofac Surg. 2008;37:156-161. (Pubitemid 351220974)
7. Hollinger JO, Schmitt JM, Hwang K, Soleymani P, Buck D. Impact of nicotine on bone healing. J Biomed Mater Res. 1999;45:294-301.
8. Saldanha JB, Pimentel SP, Casati MZ, et al. Guided bone regeneration may be negatively influenced by nicotine administration: a histologic study in dogs. J Periodontol. 2004;75:565-571.
9. Ilizarov GA. The transosseous osteosynthesis. Theoretical and clinical aspects of the regeneration and growth of tissue. New York: Springer; 1992.
10. Balbani AP, Montovani JC. Methods for smoking cessation and treatment of nicotine dependence. Braz J Otorhinolaryngol. 2005; 71:820-827.
11. Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 2002;30:472-477. (Pubitemid 34204121)
12. Midy V, Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun. 1994;199:380-386. (Pubitemid 24179960)
13. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623-628. (Pubitemid 29289424)
14. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone. 2008;43:931-940.
15. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs. 2004;176:109-119. (Pubitemid 38199424)
16. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem. 2008;283:20948-20958.
17. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ. Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol. 2003;211:105-113.
18. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002; 143:1545-1553. (Pubitemid 34274386)
19. Peng H, Usas A, Olshanski A, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 2005;20:2017-2027. (Pubitemid 41532787)
20. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci. 2008; 108:18-31.
21. Kim HH, Lee SE, Chung WJ, et al. Stabilization of hypoxia-inducible factor-1a is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine. 2002;17:14-27.
22. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004;19:176-182. (Pubitemid 39481932)
23. Riddle RC, Khatri R, Schipani E, Clemens TL. Role of hypoxia-inducible factor-1α in angiogenic-osteogenic coupling. J Mol Med. 2009;87: 583-590.
24. Fang TD, Salim A, Xia W, et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res. 2005;20:1114-1124. (Pubitemid 40863799)
25. Cramer T, Schipani E, Johnson RS, Swoboda B, Pfander D. Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1α dependent. Osteoarthritis Cartilage. 2004;12:433-439. (Pubitemid 38696943)
26. Wang Y, Wan C, Deng L, et al. The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117:1616-1626. (Pubitemid 46871346)
27. Wang Y, Wan C, Gilbert SR, Clemens TL. Oxygen sensing and osteogenesis. Ann NY Acad Sci. 2007;1117:1-11.
28. Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008;105:686-691. (Pubitemid 351171769)
29. Cheung LK, Zheng LW, Ma L. Effect of distraction rates on expression of bone morphogenetic proteins in rabbit mandibular distraction osteogenesis. J Craniomaxillofac Surg. 2006;34:263-269. (Pubitemid 43923768)
30. Lalani Z, Wong M, Brey EM, et al. Spatial and temporal localization of FGF-2 and VEGF in healing tooth extraction sockets in a rabbit model. J Oral Maxillofac Surg. 2005;63:1500-1508. (Pubitemid 41355014)
31. Emans PJ, Spaapen F, Surtel DA, et al. A novel in vivo model to study endochondral bone formation; HIF-1α activation and BMP expression. Bone. 2007;40:409-418. (Pubitemid 46054546)
32. Chen X, Gawryluk JW, Wagener JF, Ghribi O, Geiger JD. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation. 2008;5:12. (Pubitemid 351597460)
33. Tao X, Huang Y, Li R, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophicerosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:661-669.
34. van Amerongen MJ, Molema G, Plantinga J, Moorlag H, van Luyn MJ. Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice. Angiogenesis. 2002;5:173-180. (Pubitemid 36687520)
35. Kostrzewska M, Kostrzewski K, Skolasinska K, Lukasik S. Method for comparative studies of the revascularisation processes in the bone tissue, using 85Sr. Acta Physiol Pol. 1979;30:617-620. (Pubitemid 10151084)
36. Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev. 2001;100: 245-250.
37. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res. 1998; S82-89.
38. Kleinheinz J, Stratmann U, Joos U, Wiesmann HP. VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg. 2005; 63:1310-1316.
39. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials. 2006;27:3249-3255. (Pubitemid 43344337)
40. Brunello A, Saia G, Bedogni A, Scaglione D, Basso U. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma. Bone. 2009;44:173-175.
41. Holstein JH, Klein M, Garcia P, et al. Rapamycin affects early fracture healing in mice. Br J Pharmacol. 2008;154:1055-1062. (Pubitemid 351915066)
42. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone. 2001;29:560-564.
43. Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 2002;129:1893-1904. (Pubitemid 34874204)
44. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater. 2008;15:100-114.
45. Zhang Q, Tang X, Zhang ZF, Velikina R, Shi S, Le AD. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res. 2007;13:4686-4694.
46. Fleming JT, Barati MT, Beck DJ, et al. Bone blood flow and vascular reactivity. Cells Tissues Organs. 2001;169:279-284.
47. Balakumar P, Sharma R, Singh M. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacol Res. 2008;58:356-363.
48. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol. 2002;39:251-256. (Pubitemid 34084630)
49. Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ. Involvement of DDAH/ ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun. 2006;349:683-693. (Pubitemid 44344570)
50. Feitelson JB, Rowell PP, Roberts CS, Fleming JT. Two week nicotine treatment selectively increases bone vascular constriction in response to norepinephrine. J Orthop Res. 2003;21:497-502.
51. Leite MT, Gomes HC, Percario S, Russo CR, Ferreira LM. Dimethyl sulfoxide as a block to the deleterious effect of nicotine in a random skin flap in the rat. Plast Reconstr Surg. 2007;120:1819-1822. (Pubitemid 350306676)
52. Heyman SN, Goldfarb M, Rosenberger C, Shina A, Rosen S. Effect of nicotine on the renal microcirculation in anesthetized rats: a potential for medullary hypoxic injury? Am J Nephrol. 2005;25:226-232.
53. Ochiai Y, Sakurai E, Nomura A, Itoh K, Tanaka Y. Metabolism of nicotine in rat lung microvascular endothelial cells. J Pharm Pharmacol. 2006;58:403-407. (Pubitemid 43344585)
54. Black CE, Huang N, Neligan PC, et al. Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1097-1104. (Pubitemid 32948240)
55. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res. 1996; 39-46.
56. Cheung LK, Zheng LW. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in an experimental model. J Craniofac Surg. 2006;17: 100-8; discussion 109-110.
57. Boyne PJ, Nakamura A, Shabahang S. Evaluation of the long-term effect of function on rhBMP-2 regenerated hemimandibulectomy defects. Br J Oral Maxillofac Surg. 1999;37:344-352. (Pubitemid 29520471)
58. Starr AJ. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. J Bone Joint Surg Am. 2003; 85-A:2049; author replies 2049-2050.
59. Howard BK, Brown KR, Leach JL, Chang CH, Rosenthal DI. Osteoinduction using bone morphogenic protein in irradiated tissue. Arch Otolaryngol Head Neck Surg. 1998;124:985-988.
60. Oda M, Kuroda S, Kondo H, Kasugai S. Hydroxyapatite fiber material with BMP2 gene induces ectopic bone formation. J Biomed Mater Res B Appl Biomater. 2008.
61. Takayama K, Suzuki A, Manaka T, et al. RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J Bone Miner Metab. 2009.
62. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110:751-759.
63. Stylios G, Wan T, Giannoudis P. Present status and future potential of enhancing bone healing using nanotechnology. Injury. 2007;38 (Suppl 1): S63-74.
64. Kon T, Cho TJ, Aizawa T, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res. 2001;16:1004-1014.
65. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury. 2008;39 (Suppl 2): S45-57.
66. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res. 2008;87:107-118.
67. Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008; 14:179-186.
68. Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol. 1996;156:2384-2390.
69. Guslandi M. Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. Int J Colorectal Dis. 1999;14:261-262.
70. Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol. 1997;133:823-825.
71. Bartik MM, Brooks WH, Roszman TL. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol. 1993;148:408-421.
72. Cope JB, Samchukov ML, Cherkashin AM. Biologic basis of new bone formation under the influence of tension stress. In: Samchukov ML, Cope JB, Cherkashin AM, eds. Craniofacial distraction osteogenesis. Mosby, St. Louis, 2001: pp 21-36.
73. McCarthy JG, Schreiber J, Karp N, Thorne CH, Grayson BH. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg. 1992;89: 1-8; discussion 9-10.
74. Campisi P, Hamdy RC, Lauzier D, Amako M, Rauch F, Lessard ML. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg. 2003;111: 201-8; discussion 209-210.
75. Carvalho RS, Einhorn TA, Lehmann W, et al. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone. 2004;34:849-861.
76. Fang TD, Nacamuli RP, Song HM, et al. Creation and characterization of a mouse model of mandibular distraction osteogenesis. Bone. 2004;34:1004-1012.
77. Rauch F, Lauzier D, Croteau S, Travers R, Glorieux FH, Hamdy R. Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone. 2000; 27:453-459.
78. Sato M, Ochi T, Nakase T, et al. Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res. 1999;14:1084-1095.